Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics-Reference-Cited by-同舟云学术

Gentamicin as Empirical Treatment in Hemodialysis Patients: Safety, Pharmacokinetics, and Pharmacodynamics

Published:2019-06-27 Issue:6 Volume:23 Page:550-555
ISSN:1744-9979
Container-title:Therapeutic Apheresis and Dialysis
language:en
Short-container-title:Ther Apher Dial

Author:

Guisado‐Gil Ana B¹^ORCID,Herrera‐Hidalgo Laura¹,Santos‐Rubio María D¹,Gil‐Sacaluga Luis²,Molina José³,Lepe‐Jiménez José A³,Camacho‐Martínez Pedro³,Gil‐Navarro María V¹

Affiliation:

1. Department of PharmacyUniversity Hospital Virgen del Rocio Seville Spain

2. Department of NephrologyUniversity Hospital Virgen del Rocio Seville Spain

3. Department of Infectious Diseases, Microbiology and Preventive MedicineUniversity Hospital Virgen del Rocio Seville Spain

Publisher

Wiley

Subject

Nephrology,Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.12810

Reference24 articles.

1. Aminoglycosides in Intermittent Hemodialysis: Pharmacokinetics with Individual Dosing

2. Clinical Experience with Aminoglycosides in Dialysis-Dependent Patients: Risk Factors for Mortality and Reassessment of Current Dosing Practices

3. Aminoglycosides in Hemodialysis Patients: Is the Current Practice of Post Dialysis Dosing Appropriate?

4. Development of a Semimechanistic Model to Describe the Pharmacokinetics of Gentamicin in Patients Receiving Hemodialysis

5. Pharmacokinetics and administration method of gentamicin in a patient on haemodialysis

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Drug Monitoring of Antibiotic Drugs in Patients Receiving Continuous Renal Replacement Therapy or Intermittent Hemodialysis: A Critical Review;Therapeutic Drug Monitoring;2022-02

2. Pharmacokinetics of Tobramycin Administered at the Beginning of Intermittent Hemodialysis Session (ESRD Study);Canadian Journal of Kidney Health and Disease;2021-01